These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11908224)

  • 1. Myasthenia gravis.
    Vincent A; Drachman DB
    Adv Neurol; 2002; 88():159-88. PubMed ID: 11908224
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy of myasthenia gravis.
    Drachman DB
    Handb Clin Neurol; 2008; 91():253-72. PubMed ID: 18631846
    [No Abstract]   [Full Text] [Related]  

  • 3. Mechanisms of action of IVIG in adult onset Rasmussen's encephalitis.
    Buenz EJ; Howe CL
    Can J Neurol Sci; 2007 Feb; 34(1):108-9. PubMed ID: 17352358
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation and management of myasthenia gravis.
    Keesey JC
    Muscle Nerve; 2004 Apr; 29(4):484-505. PubMed ID: 15052614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myasthenia gravis. Its pathophysiology, diagnosis, and treatment.
    Lin JT; Singer PA
    J Kans Med Soc; 1983 Feb; 84(2):53-8, 60. PubMed ID: 6833821
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment and clinical research in myasthenia gravis: how far have we come?
    Barohn RJ
    Ann N Y Acad Sci; 2008; 1132():225-32. PubMed ID: 18567872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myasthenia gravis.
    Drachman DB
    N Engl J Med; 1994 Jun; 330(25):1797-810. PubMed ID: 8190158
    [No Abstract]   [Full Text] [Related]  

  • 8. The limitation of IL-10-exposed dendritic cells in the treatment of experimental autoimmune myasthenia gravis and myasthenia gravis.
    Xiao BG; Duan RS; Zhu WH; Lu CZ
    Cell Immunol; 2006 Jun; 241(2):95-101. PubMed ID: 17005165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-specific immunotherapy in myasthenia gravis: failed promise and new hope.
    Pachner AR
    J Neuroimmunol; 2004 Jul; 152(1-2):vii-viii. PubMed ID: 15223253
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic strategy in myasthenia gravis].
    Tranchant C
    Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-MuSK antibodies: correlation with myasthenia gravis severity.
    Bartoccioni E; Scuderi F; Minicuci GM; Marino M; Ciaraffa F; Evoli A
    Neurology; 2006 Aug; 67(3):505-7. PubMed ID: 16894117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IVIg in polymyositis and myasthenia gravis.
    Cosi V; Piccolo G
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():499-505. PubMed ID: 10689500
    [No Abstract]   [Full Text] [Related]  

  • 13. Myasthenia gravis: pathophysiology and management.
    Ann N Y Acad Sci; 1981; 377():1-902. PubMed ID: 6951467
    [No Abstract]   [Full Text] [Related]  

  • 14. Does early immunotherapy reduce the conversion of ocular myasthenia gravis to generalized myasthenia gravis?
    Kupersmith MJ
    J Neuroophthalmol; 2003 Dec; 23(4):249-50. PubMed ID: 14663302
    [No Abstract]   [Full Text] [Related]  

  • 15. Juvenile myasthenia gravis: three case reports and a literature review.
    Gadient P; Bolton J; Puri V
    J Child Neurol; 2009 May; 24(5):584-90. PubMed ID: 19406758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dental management of patients with myasthenia gravis: a literature review.
    Yarom N; Barnea E; Nissan J; Gorsky M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Aug; 100(2):158-63. PubMed ID: 16037773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune myasthenia gravis in childhood.
    Andrews PI
    Semin Neurol; 2004 Mar; 24(1):101-10. PubMed ID: 15229797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myasthenia gravis. Evolution of research at the Neurologic Clinic of the Clinical Hospital of the University of São Paulo Medical School].
    De Assis JL
    Arq Neuropsiquiatr; 1986 Dec; 44(4):406-14. PubMed ID: 3606434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis.
    Tüzün E; Saini SS; Ghosh S; Rowin J; Meriggioli MN; Christadoss P
    Neuromuscul Disord; 2006 Feb; 16(2):137-43. PubMed ID: 16427283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distal myasthenia gravis.
    Renard D; Castelnovo G; Labauge P
    Acta Neurol Belg; 2008 Sep; 108(3):107-8. PubMed ID: 19115675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.